PGY2 Medication-Use Safety and Policy Pharmacy Resident

The PGY2 Medication-Use Safety and Policy Residency is a structured 12-month PGY2 residency program that provides advanced training in medication safety, medication-use policy, regulatory and accreditation standards, and quality improvement. Residents completing the program will be well prepared to assume roles including: those with responsibility for developing and implementing system changes that improve the safety within the medication-use system; managing medication-use guidelines and policies; and overseeing regulatory and accreditation compliance.

The resident will work closely with members of Medication Safety, Quality, and Regulatory team to investigate medication errors and near misses, develop and implement system changes to ensure safe and efficient use of medications, assess compliance with regulatory standards, and evaluate medication-use policies and guidelines to ensure alignment with evidence-based best practice recommendations. The resident will learn about the operations of a cancer center through required learning experiences, participation in formal education programs, administrative projects, and staffing in the ambulatory infusion pharmacy.

For more information, please visit our website for a detailed description of residency activities, contact information, and important deadlines.

https://www.dana-farber.org/for-physicians/education-and-training/fellowships-and-training-programs/pharmacy-residency-programs/

Applicants must expect to complete an ASHP accredited PGY-1 pharmacy residency and be licensed in the state of Massachusetts by summer of 2026. Application requirements: Complete PhORCAS application by Monday, January 4, 2027.

PPS interviews will be conducted on Sunday, December 6th through Tuesday December 8th. For consideration for an interview, please send a message through the PPS messenger.